UN&UP One of Only 17 Companies Awarded a Blueprint MedTech Cycle I Award for its Novel Thrombolysis Platform for Acute Ischemic Stroke

Blueprint MedTech is funded by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Drug Abuse (NIDA), the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and by the Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative.

NeuroTech Harbor’s (NTH) mission is to accelerate the development of innovative and groundbreaking solutions that aim to improve neurological health for all. Reflecting Equitech values of inclusivity, equity, and accessibility while providing funding, resources, and guidance from seasoned neurotech scientists and entrepreneurs, NTH will enable innovators to take their solutions to the next level.

Find more information at the sites below:

https://www.nibib.nih.gov/news-events/newsroom/nih-blueprint-medtech-spurs-innovation-diagnosing-and-treating-nervous-system-disorders

https://neurotechharbor.org/2023/11/16/blueprint-medtech-cycle-1-seedling-awardees/